Lose Your Belly Fat Fast

Flat Belly Fix

In Flat Belly Fix program, you learn the easy, tested and trusted method that saved the creator of this program (Todd Lamb) beautiful wife Tara from a life battling Type 2 Diabetes and experiencing possibly death. It was a very nasty experience with the couple during those times, but with the determination of Todd, he labored ceaselessly to finding a way out for his depressed and unhappy wife. Now they live together both happy and contented. Having used the same technique for people around (seeing the wonders it did to his wife) and also recording so much success, Todd Lamb wants to relate this secret to the world, to create this same atmosphere of joy produced in his immediate environment. Hence, he was motivated to put together this workable program. You also get to learn the secret to having a flat belly, and a healthy and fit body that has been hidden from you for so long now. The creator if this program is positive about the efficacy of this program and is so excited for you to personally experience what happens when you apply The 21 Day Flat Belly Fix in your life. More here...

Flat Belly Fix Summary


4.8 stars out of 218 votes

Contents: Ebooks, Videos
Author: Todd Lamb
Official Website: theflatbellyfix.com
Price: $37.00

Access Now

My Flat Belly Fix Review

Highly Recommended

The very first point I want to make certain that Flat Belly Fix definitely offers the greatest results.

As a whole, this ebook contains everything you need to know about this subject. I would recommend it as a guide for beginners as well as experts and everyone in between.

Lean Belly Breakthrough

This product designed by a great doctor in Germany breaks the conventional media knowledge of health improvement and weight loss by introducing a simple 2-minute ritual daily to be on your way for a life full of happiness and fewer worries about health. The program was also co-created by Bruce who is a knownsuccessfulexperienced personal trainer who coached celebrities and was hosted on TV shows to discuss health issues. He combined his knowledge of training into heinrick's methods of health and weight loss to get people to lose up to dozens of deadly weight. The final product includes a set of books and videos created to help you boost your health. It will also help you reverse diabetes, discover of you will have a heart attack and evade, boost sex drive and youthfulness. Moreover, this program includes herbs and minerals to consume daily so you watch your body fat melt away by the day. You do not have to worry about the ordering procedure as this method will offer easy instructions and instant access to the material in no time. Your life ahead will be fullof joy and less of health anxiety. Furthermore, you won't have to buy those expensive supplements and take in sessions with personal trainers that know nothing. More here...

Lean Belly Breakthrough Summary

Contents: Ebooks, Videos, Audios
Author: Bruce Krahn
Official Website: www.leanbellybreakthrough.com
Price: $37.00

Risk factors for chronic disease The metabolic syndrome MetS

The metabolic syndrome (MetS) is a combination of medical disorders integrated to have a useful description of related cardiovascular risk factors which also predict the risk of developing diabetes. Although there have been arguments against the use of a minimalistic view for these diseases, there is currently a unifying definition for the MetS (Fig. 3.1). According to this (Alberti et al., 2006), obesity and insulin resistance appear to be the causative factors in the development of the MetS. General features include obesity, insulin resistance (correlated with the risk of Type 2 diabetes and CVD), atherogenic dyslipidemia (increased triglycerides and HDL cholesterol), elevated BP, elevated C-reactive protein (CRP proinflammatory state), and a prothrombic state, associated with coagulation and fibrinolytic proteins. Scientific effort has been done to clarify associations between MetS factors, and after decades of effort, some facts can be stated

Metabolic syndrome prevention

Enzyme (ACE-I) by peptides isolated from hot water extracts (Suetsuna et al., 2004 Suetsuna and Nakano, 2000). Inhibition of ACE-I is considered to be a useful therapeutic approach in the treatment of hypertension and inhibitors such as captopril, enalapril, alcacepril, and lisinopril, which are currently used in the treatment of essential hypertension and heart failure in humans. Peptides from wakame can be a better alternative, as natural products might have less secondary effects. Another beneficial effect of wakame has been reported to be against the development of stroke in stroke-prone spontaneously hypertensive rats putatively due to fucoxan-thin (Ikeda et al., 2003). Other studies suggest that wakame and dietary fish oil synergistically decrease rat serum and liver triacylglycerol (Murata et al., 2002), effect attributable to stimulation of enzymes involved in hepatic fatty acid oxidation (Murata et al., 1999). Of particular interest in clinical studies are dose dependency...

An Overview Of Metabolic Syndrome A Precursor Of Diabetes Heart Disease And Stroke

Energy is stored as adenosine triphosphate (ATP), which is produced in subcellular compartments called mitochondria. ATP activates biomolecules and drives, either directly or indirectly, much of the biosynthesis, development, regulation and repair required for life. Consequently, diseases arising from inefficiency (or misregulation) of energy production and metabolism have profound effects on health. Illness of this type was defined as metabolic syndrome by G.M. Reaven in 1988. This term encompasses a wide variety of molecular abnormalities which can result in During the last 30 years metabolic syndrome has become increasingly common, and currently affects more than 50 million people in the US. Much of this increase is associated with higher caloric intake (especially of sugar and saturated fats), reduced physical activity and exercise, and an aging population.1 The earliest sign of metabolic syndrome is the presence of one or more of the following symptoms Individuals who have two or...

Stress Obesity and Metabolic Syndrome

Healthy individuals respond to stress in a unitary fashion with the activation, as mentioned already, of the sympatho-adrenal system and the HPA axis resulting in an increase of cortisol and epinephrine. One immediate consequence of this is an increase in resting heart rate and a reduction of vascular resistance. In those individuals who are obese or have insulin resistance, endothelial dysfunction can dampen the compensatory reduction of blood pressure and limit glucose disposal in response to stress. These events can lead to central obesity and the development of certain features of the MetS. In summary, stress may play an important mediator in both schizophrenia and the MetS. Activation of the HPA axis is a consequence of physical and psychological stressors, the latter including perceived threats to self-integrity and esteem. Dysfunction of the HPA axis occurs in both MetS and schizophrenia. Although cortisol is crucial for life, in excess can become the source of hippocampal...

Preface to the Series

The editors have chosen topics from both important therapeutic areas and from work that advances the discipline of medicinal chemistry. For example, cancer, metabolic syndrome and Alzheimer's disease are fields in which academia and industry are heavily invested to discover new drugs because of their considerable unmet medical need. The editors have therefore prioritized covering new developments in medicinal chemistry in these fields. In addition, important advances in the discipline, such as fragment-based drug design and other aspects of new lead-seeking approaches, are also planned for early volumes in this series. Each volume thus offers a unique opportunity to capture the most up-to-date perspective in an area of medicinal chemistry.

Sex Differences in Insulin Resistance

Insulin resistance can vary between sexes and across a women's reproductive life cycle. For example, some studies have suggested that girls through adolescence are inherently more insulin resistant than boys, but this relationship is thought to reverse after puberty 3, 4 . In adults, fat distribution patterns favor the development of IR in men, as men are more likely to develop abdominal obesity. Abdominal fat tissue is a major source of free fatty acids and cytokines and is associated with IR 5 . Premenopausal adult women more frequently develop peripheral obesity with subcutaneous fat accumulation, whereas men and postmenopausal women are more prone to central or abdominal obesity. After the menopause, concentrations of lipoproteins as well as body fat distribution shift to a more male pattern 5 . Pregnancy is also a time of elevated peripheral IR for women. During pregnancy, there is an approximate 50 reduction in insulin sensitivity by the third trimester such changes are thought...

Proteins Secreted by Visceral Adipose Tissue

Called adipokines, which have pleiotropic effects on a variety of metabolic pathways 48,51 . Proteins released from adipose tissue include regulators of inflammation, inducers of angiogenesis, and modulators of hypertension, among others. Visceral adipose tissue, in particular, has been implicated in the release of proteins responsible for metabolic syndrome and type 2 diabetes 52 . For this reason, evaluation of visceral adipose tissue, either alone or in comparison to subcutaneous adipose tissue, is of great interest 52,53 .

Specific Metabolic Features of Women with Bipolar Disorder

Metabolic Syndrome and a propensity towards higher waist circumferences 10 . Obese patients with either BD or schizophrenia are more likely to be women 30 , and weight gain has been shown to be associated with female sex 31 . An evaluation of data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) demonstrated greater rates of obesity in bipolar women (31 ), compared to bipolar men (21 ) in contrast, there were greater rates of overweight in bipolar men (38 ), compared to women (22 ) 32 , a finding consistent with previous studies 33 . Women with BD appear to have a higher likelihood of increased waist circumference than men with BD, suggesting a sex-specific vulnerability to IR in BD. Changes in weight and appetite are found more commonly in women than in men with BD 34, 35 . Higher rates of thyroid and eating disorders are seen in women with BD 36 . Factors that influence the onset and maintenance of obesity in BD include both gender and eating behavior...

New therapeutic drugs from studies of endocannabinoid synthesis and degradation

The recent development of Rimonabant (Sanofi-Aventis, Paris, France), a selective cannabi-noid CB1 receptor antagonist inverse agonist, as an efficacious anti-obesity agent with possible use also against the metabolic syndrome (Van Gaal et al. 2005), and the future marketing in Canada of Sativex (GW Pharmaceuticals, Salisbury, UK), a pharmaceutical preparation based on a Cannabis extract against neuropathic pain in multiple sclerosis, might one day be followed by the use of therapeutic drugs that also manipulate the levels rather than the action of endocannabinoids, thereby influencing the tone of cannabinoid receptors indirectly. For example, given the strong weight of endogenous 2-AG in the activation of cannabinoid receptors, inhibitors of the DAGL might produce a blockade of endocannabinoid signalling similar to that caused by receptor antagonists, and hence, like the latter compounds, find an application in those disorders where, at least in animal models, excessive...

Prevalence of Glucose Abnormalities in Schizophrenia

The Belgian group under De Hert has produced some interesting naturalistic data from a consecutive prospective cohort of 415 schizophrenia subjects 24 . They report that the difference in DM prevalence between schizophrenia subjects and a control population increases with increasing age being 1.6 in the 15- to 25-year cohort and 19.2 in the 55- to 65-year cohort. Using OGTT, they identified more DM cases than by fasting glycaemia (FG) alone which would have identified only 46.2 of DM cases. In comparing cohorts, they divided subjects into cohorts 5.6 mmol l (the inclusion criteria for metabolic syndrome IDF) was found to increase from 8 to 40.5 .

Potential Pathophysiological Mechanisms for Glucose Elevation

Population, we know that type 2 diabetes may take up to 10 years from initial abnormality to elevated glucose. No clinical trial in modern-day psychiatry exceeds 3 years 41 . Thus, proposed mechanisms are speculative and include weight-gain associated increases in insulin resistance, a direct toxic drug effect on muscle or adipose tissue leading to insulin resistance, stimulation of hepatic glucose production and inhibition of insulin release through pancreatic toxicity. The quantitative role of abnormally elevated amounts of visceral fat 42, 43 present in treatment-naive subjects (over three times greater than that in controls) and any other additional genetic predisposition to DM versus any treatment or lifestyle associated association is unknown. 44 . Data from a 6-month randomised trial of schizophrenia subjects with baseline BMI 28-30 randomised to olanzapine or risperidone found no worsening or differences between the groups on parameters such as insulin sensitivity and...

Typeii Diabetes Mellitus

Reaven (1988) suggested that insulin resistance might be a common denominator for obesity, Type-II diabetes hypertension and hyperlipidaemia (metabolic syndrome) and should be treated rigorously to avoid coronary heart disease, the most common cause of morbidity and mortality in Type-II diabetes mellitus. However, it still remains to be proven that effective blood glucose control will reduce the mortality of the disease (Turner and Holman, 1990).

Antiobesity effects of seaweeds

The parauterus adipose tissue weight, and hepatic TG, serum TG, and TC levels in the HFD-TK group were significantly less than those in the HFD-NSK group. The fecal TG and TC levels in the HFD-TK group were significantly higher than those in the HFD group, and fecal TG in the HFD-TK-group was significantly higher than that in the HFD-NSK group. Consequently, it was demonstrated that TK consumption reduced the accumulation of visceral fat caused by HFD, and this effect of TK was more powerful than that of NSK, due to TG and cholesterol excretion in the feces. This report concluded that alginate may be one of the active components in Laminaria sp. In previous reports, alginate has been reported to have hypoglycemic and cholesterol-lowering effects by acting as a viscous soluble dietary fiber (Kimura et al., 1996 Pasquier et al., 1996 Paxman et al., 2008).

Subunits Associated with Complex Phenotypes

While many reports find an association between the C825T allele of GNB3 and other features of the metabolic syndrome, including obesity, insulin resistance, auto-nomic nervous changes, and dyslipidemia (58-61), the results are not unanimous (62-65). The polymorphism has also been implicated in Alzheimer's disease (66), sudden death (67), and tumor progression (68,69) and as a pharmacogenetic marker for drug response (57,70-73). The mechanisms linking the C825T polymorphism to clinical outcomes have not been identified. The GNB3 polymorphisms, however, may become useful markers for disease risk and altered drug response.

Adverse Effects And Drug Interactions

Fibrates are the drugs of choice for treating hyperlipidemic subjects with type III hyperlipoproteinemia and for subjects with severe hypertriglyceridemia (triglycerides 1000 mg dL) who are at risk for pancreatitis. Fibrates appear to have an important role in subjects with high triglycerides and low HDL-C levels associated with the metabolic syndrome or type 2 diabetes mellitus. In these settings, the LDL levels should be monitored if LDL levels rise, the addition of a low dose of a statin may be needed. Many experts now treat such patients first with a statin, and then add a fibrate, based on the reported benefit of gemfibrozil therapy. If this combination is used, there should be careful monitoring for myopathy.

The Screening Programme

The cost of screening for diabetes and cardiovascular disease is low in most countries, where all the blood tests are performed routinely in hospital biochemistry laboratories. Similarly the measurement of blood pressure, weight and waist circumference is undertaken cheaply. There are costs involved with the management by health care professionals of any screening programme and there are additional treatment costs for those identified with diabetes or cardiovascular disease.

Tolerability and Safety

Weight gain was formerly seen as a largely cosmetic problem. It is now realized to be a much more important because obesity combined with lack of exercise and smoking is associated with the so-called metabolic syndrome. This is a composite term for biochemical, blood pressure, and weight indices associated with older age and higher body mass index. It is the prelude to diabetes, coronary heart disease, and stroke. Several antipsychotics used to treat bipolar disorder, including clozapine, olanza-pine, and quetiapine are particularly associated with increased weight gain and the risk of dyslipidaemia, hypercholesterolaemia, and elevated glucose. In an increasingly obese population, this is a growing concern and requires active prevention wherever possible and treatment of risk factors.

Atypical Antipsychotic Augmentation of SSRI

Despite strong data for efficacy, adequate dose response studies have not been done, long-term efficacy has not been studied, and antipsychotics as a class have been associated with serious adverse effects such as metabolic syndrome and extrapyramidal syndromes (although EPS are of a less concern with atypicals, they can occur).

Second Generation Antipsychotics

Switching antipsychotics can lead to weight loss. Ultimately, there will need to be a favorable balance of benefit to risk 29 . Deciding whether to continue treatment with a particular antipsychotic or switch the patient to another can pose substantial dilemmas for the clinician. The choice to 'switch or stay' is a highly individualized decision. Evidence-based medicine philosophy states that relevant clinical trials can inform the clinician in making thoughtful individualized treatment decisions but there are no guarantees of weight gain or loss or drug efficacy. With these caveats, consideration should be given to switching to a more weight-neutral medication when encountering rapid weight gain with a particular antipsychotic. For example, in the CATIE study, of 61 patients who gained over 7 of their body weight in phase 1, 42 of ziprasi-done-treated patients, 20 of risperidone-treated patients, 7 of quetiapine-treated patients, and 0 of olanzapine-treated patients lost over 7 of...

Immune Changes in Schizophrenia

Another interesting connection between schizophrenia and the immune system has been provided by the susceptibility of first-degree relatives of schizophrenic patients to insulin-dependent diabetes mellitus. This susceptibility appears to be associated with the HLA locus on chromosome 6 8 . Such an observation is particularly important because of the association between the metabolic syndrome and type 2 diabetes in schizophrenic patients being treated with the second-generation antipsychotic olanzapine. Clearly, there are differences in the genetic signal between type 1 and type 2 diabetes. Thus, there appears to be a decrease in the frequency of schizophrenia in patients with type 1 diabetes 9 , which suggests that insulin, as such, is not directly linked to the pathology of schizophrenia. As is becoming apparent, type 2 diabetes is a possible consequence of dysfunctional metabolism initiated by immune, endocrine and mitochondrial changes that are symptomatic of schizophrenia.

Central and Physical Effects of Hypercortisolaemia

Yet GCs also have peripheral effects as manifested by Cushing's disease (due to a pituitary basophil adenoma) or Cushing's syndrome (most commonly due to exogenous steroid administration) 41, 42 . GR are also located peripherally, for example in subcutaneous and visceral fat deposits, and it should come as no surprise that high levels of cortisol have peripheral effects such as increasing visceral fat deposits 43, 44 . Upper body fat, which consists of subcutaneous and visceral fat depots as is defined as a waist to hip ratio of 0.85 in women and 0.95 in men, is associated with greater metabolic disturbance than those with a predominantly lower fat distribution 45 . The exact mechanisms that underlie this process are still incompletely understood. However, we do know that obesity and free fatty acids (FFAs) in excess 46-49 leads to in GR receptor density within visceral fat stores and an alteration in the activity of key enzymes which are known to reduce fat stores within the abdomen...


Alternate definitions have focused on waist-to-hip ratios or waist circumference used in the definitions for metabolic syndrome developed by the World Health Organization and the National Cholesterol Education Program Expert Panel on Moreover, these definitions may not apply in all ethnic groups. For example, waist circumference for Asians is generally lower, requiring a lower cut-off of 90 cm in men (instead of 102 cm in the NCEP definition) or 80 cm in women (instead of 88 cm), when assessing the prevalence of central obesity 8 . In Japan, the definition of obesity is a BMI of at least 25, rather than the 30 used among Caucasians 9 .


Patients with schizophrenia have higher rates of obesity 15 . Among the patients participating in phase 1 of the randomized and double-blinded 18-month Clinical Antipsychotic Trials of Intervention Effectiveness schizophrenia study (CATIE), the mean BMI was 30 16 . Moreover, waist circumference exceeded norms for 46 of all subjects (n 1435), 37 of all men (n 1059), 73 of all women (n 376), 48 of all Caucasians (n 858), 43 of all Blacks (n 504), and 47 of all Hispanics (n 167).

Meal Composition

Humans have a significant direct influence on macronutrient metabolism 25, 26 . Cortisol seems to increase lipolysis and proteolysis, as well as increasing gluconeogenesis, thereby raising the contribution of protein and fat to energy substrate supply, while protecting glycogen stores. Further, the ability of cortisol to increase plasma free fatty acid (FFA) levels may underlie the emerging link between cortisol and abdominal obesity, together with its associated metabolic syndrome 27 . It has been suggested that dietary fat is a prime contributor to the development of obesity 46 . For any given body mass index, mortality is higher if fat is distributed centrally (visceral adiposity) compared with a more generalized pattern of distribution 52 . This has renewed interest in the factors that control adipose tissue distribution in addition to adipose tissue mass and function 53 . Although men tend to progressively increase abdominal fat deposits with increasing total adiposity at each...

GPCR Signaling

Several human disorders result from genetic G protein abnormalities. Several involve the imprinted GNAS gene, which encodes Gsa, the ubiquitously expressed a-subunit that couples receptors to adenylyl cyclase (AC), causing cyclic adenosine monophosphate (cAMP) generation. Loss-of-function, gain-of-function mutations and imprinting defects lead to many clinical phenotypes. Mutations of GNAT1 and GNAT2, which encode the retinal G proteins (transducins), cause specific congenital visual defects. Common polymorphisms of the GNAS and GNB3 (which encodes GP3) genes have been associated with multigenic disorders (e.g., hypertension and metabolic syndrome). To date, only variants of the a- and P-subunits of the G protein have been implicated in human disease. No y-subunit disruptions have been identified. A general overview of G protein coupling is necessary before a description of the G protein, accessory protein, and GPCR variants associated with disease is undertaken.


In relation to health, dysfunction of the HPA axis has been implicated in particular in dysphoric disorders, such as major depression 259 , whereas hypercortisolemia in Cushing's syndrome is accompanied by physical symptoms, such as accumulation of abdominal adipose tissue, together with muscular atrophy of the limbs, providing powerful evidence of the well-established metabolic and nutritional consequences of chronic hypercortiso-lemia 94 . Normal physiological variations in cortisol level in humans have a significant direct influence on macronutrient metabolism 25, 26 . Also, the ability of cortisol to increase plasma FFA levels may underlie the emerging link between cortisol and abdominal obesity, together with its associated metabolic syndrome 27 .


Clinical symptoms of AD include cognitive impairment, memory loss and disorientation. Increasing evidence suggests that risk for AD can be influenced by life style choices such as diet and exercise that directly affect metabolism. Moreover, concurrent metabolic diseases such as diabetes, metabolic syndrome, atherosclerosis and other types of cardiovascular disease are associated with an increased risk for AD 23,24 . Thus, the physiological status of peripheral organ systems impacts the central nervous system and affects biological processes that are critical to the pathogenesis of AD. The relationships between insulin resistance, inflammation, cholesterol homeostasis and PPARy in AD are summarized in Fig. 2.


The chronic mild stress procedure in rats decreased sucrose intake per unit body weight, while sucrose intake in a nonstressed control group did not change 309 .There was not any correlation between body weight and sucrose intake. Sucrose intake was reduced while body weight remained unaffected 309 . The largest effect was obtained after 2 weeks of the stress protocol, this effect was attenuated afterward 309 . D'Aquila et al. 310 also observed a recovery of reward behavior'' in the chronic mild stress model. Overeating of comfort foods'' in humans may be stimulated by cortisol in response to stress, which can result in abdominal obesity 311 . Although acute elevation of cortisol plays a protective role during stress, persistently elevated levels promote insulin resistance and abdominal obesity 312, 313 . Insulin resistance might be followed by both dyslipidemia and elevated blood pressure 314 . Cortisol secretion as a response to perceived stress is a powerful factor regulating...

The Condition

Metabolic syndrome The risk factors for cardiovascular disease are well recognised and like those for diabetes can be divided into unmodifiable and modifiable risk factors (table 2). The metabolic syndrome, which is defined by a cluster of cardiovascular risk factors, is associated with around a 75 increased risk of cardiovascular disease. How the presence of this should be used to aid the identification of those at highest risk remains the subject of debate.

The Test

No research has been performed to determine the acceptability of diabetes and CVD disease screening in people with SMI. Our own experience would suggest that patient acceptability may be an issue. Locally, we have undertaken a study to evaluate the prevalence of diabetes and metabolic syndrome among people with schizophrenia and bipolar illness living in different settings. We have invited individuals to undergo physical health screening and have experienced suspicion and lack of consent from some people with SMI. This may reflect the nature of a research study and therefore physical health screening may be easier to undertake in routine clinical practice but this should not be assumed.


There is considerable excitement surrounding the initial success of clinical trials of PPARy agonists in treatment of AD. The complex biology of this receptor and our poor understanding of their actions in the brain present a number of challenges in understanding its modes of action. It seems probable that PPARy works through multiple mechanisms to elicit its effects. Remarkably, there is almost nothing known about PPARy action in neurons and this is an area that needs to be investigated. The capacity of this receptor to act to coordinate lipid and carbohydrate metabolism suggests mechanistic linkages to peripheral organ systems. The association of diabetes, dyslipi-demia and metabolic syndrome with increased risk for AD underscores the potential roles PPARy might play in treatment of AD and emphasizes the importance of our understanding of AD within the larger context of metabolism.


1MetS Metabolic syndrome ( 3 ATP III criteria present). 2Limited to those with all 5 ATP III measures. 3 1 of the 5 ATP III criteria. Fig. 1. Prevalence of each MetS criterion by race gender. WF White female, WM white male, BF black female, BM black male, LF Latina female, LM Latino male, WC waist circumference 102 cm for men or 88 cm for women, Trig triglycerides 150 mg dl, HDL cholesterol 102 cm for men or 88 cm for women, Trig triglycerides 150 mg dl, HDL cholesterol 102 cm for men or 88 cm for women, Trig triglycerides 150 mg dl, HDL cholesterol 102 cm for men or 88 cm for women, Trig triglycerides 150 mg dl, HDL cholesterol

SIRT1 and T2D

Considering the physiological effects of SIRT1 activity, SIRT1 activation has clear potential to combat numerous age-associated diseases, including metabolic syndrome, type 2 diabetes, cardiovascular disease, and neurodegenerative diseases (Borradaile and Pickering 2009 Ginsberg and MacCallum 2009 Hwang et al. 2009 Liu et al. 2008b Milne et al. 2007 Picard et al. 2004 Qin et al. 2006 Ramsey et al. 2008 Sun et al. 2007). Augmentation of SIRT1 activity may also combat functional declines that occur with normal aging (Marton et al. 2010 Revollo et al. 2007). With this degree of potential, small-molecule sirtuin activating compounds (STACs) have been searched for and developed. One approach that may solve all these problems is to augment NAD levels through dietary supplementation of NAD substrates and intermediates. As these compounds are natural biological entities, they could be taken in the absence of disease pathology, potentially enhancing normal bodily functions throughout life. As...


Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord 2000 24(Suppl. 2) S80-S85. 315 Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998 83(6) 1853-1859.


Defining Metabolic Syndrome There are different definitions of MetS, the most commonly referenced of which are those proposed by the National Cholesterol Education Program Adult Treatment Panel III (ATP-III), European Group for the Study of Insulin Resistance (EGIR), International Diabetes Federation Epidemiology Task Force Consensus Group (IDF), American Heart Association National Heart, Lung, and Blood Institute (AHA NHLBI), World Health Organization (WHO), and the American Association of Clinical Endocrinologists (AACE) 12, 14-18 . All include assessment of body fat, dyslipidemia, blood pressure, and glucose dysregulation, but different metrics and cutoffs are used. The most common measures of body fat are waist circumference (ATP-III, EGIR, IDF, AHA NHLBI) and BMI (WHO, AACE) 12, 14-18 . Dyslipidemia measures include triglycerides ( 150 For this study, the ATP III definition of MetS was used 14 . It requires the presence of at least three of five specified criteria FBS 110 mg dl,...

Fire Up Your Core

Fire Up Your Core

If you weaken the center of any freestanding structure it becomes unstable. Eventually, everyday wear-and-tear takes its toll, causing the structure to buckle under pressure. This is exactly what happens when the core muscles are weak – it compromises your body’s ability to support the frame properly. In recent years, there has been a lot of buzz about the importance of a strong core – and there is a valid reason for this. The core is where all of the powerful movements in the body originate – so it can essentially be thought of as your “center of power.”

Get My Free Ebook